番茄社区

Ian Ingram

Ian Ingram

Authors >

Ian Ingram

Ian Ingram joined 番茄社区 in 2018 as Deputy Managing Editor, and covers oncology for the site. Ian Ingram has been a medical editor for the past decade. Prior to joining 番茄社区, he was managing editor of Cancer Network, directing the website鈥檚 news coverage and video production. Ian has also worked as a fact-checker, was an assistant editor at Narrative Magazine, and a manuscript reader at the Paris Review. He holds a B.A. in journalism from Purchase College. Ian lives in Connecticut, enjoys tennis, and almost always bowls a perfect game.

Connect:

email image

Latest from Ian Ingram

A photo of a man with his eyes closed laying on his stomach on a couch in the daytime.

Drug Hints at Benefit for Long COVID Fatigue in Small Trial

Phase II study misses main goal, but developer charts regulatory path around fatigue endpoint

FDA MARKETING MISHA Knee System over a computer rending of the device.

FDA Clears Shock-Absorbing Implant for Refractory Knee OA

MISHA Knee System indicated for medial knee osteoarthritis not advanced enough for arthroplasty

A photo of a toe tag on a body in the morgue which reads: COVID-19.

Yes, COVID Is Still Deadlier Than the Flu

VA study finds 61% higher mortality rate in hospitalized cases this past winter

A photo of a male physician putting a pulse oximeter on the finger of a senior woman receiving a colonoscopy.

Does Your 80-Year-Old Patient Really Need That Colonoscopy?

Physicians often ignore life expectancy in screening decisions, study finds

A computer rendering of colon polyps.

Take Risk Into Account Before Repeat Surveillance Colonoscopy, Study Says

58% of seniors with limited life expectancy, no significant findings invited for another round

A computer rendering of ulcerative colitis.

IL-6 Inhibitor for UC Shows Some Promise in Mid-Stage Trial

Though next steps for olamkicept in ulcerative colitis a bit unclear

FDA APPROVED velmanase alfa (Lamzede) over a photo of two toddler boys affected by alpha-mannosidosis

FDA OKs First Therapy for Alpha-Mannosidosis

Velmanase alfa approved for treating non-CNS manifestations of progressive, inherited disease

A photo of a box of the Pfizer-BioNTech bivalent COVID-19 vaccine

CDC, FDA Flag Early Signal of Stroke Risk With Bivalent COVID Vaccine

One surveillance system detects potential link in seniors, yet multiple others show none

ASH over a photo of Ernest N. Morial Convention Center in New Orleans, Louisiana.

New Regimen for GvHD Prophylaxis in Well-Matched Reduced-Intensity Allo-HCT

Post-transplant cyclophosphamide, tacrolimus, and MMF reduces GvHD without higher relapse risk

ASH over a photo of Ernest N. Morial Convention Center in New Orleans, Louisiana.

High-Dose Chemo, ASCT Improves Survival in Primary CNS Lymphoma

European trial is "practice-changing as of today," says U.S. expert

鈥�

12

鈥�